메뉴 건너뛰기




Volumn 4, Issue 1, 2006, Pages 53-59

Pathophysiological basis for anticoagulant and antithrombotic therapy in pulmonary hypertension

Author keywords

Anticoagulant therapy; Antiplatelet drugs; Endothelial dysfunction; Hypoxia; Platelets; Pulmonary hypertension; Thrombophilia; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; CYTOKINE; ENDOTHELIN 1; NITRIC OXIDE; PADGEM PROTEIN; PHOSPHOLIPID ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTACYCLIN; SEROTONIN; THROMBOMODULIN; THROMBOXANE; TISSUE PLASMINOGEN ACTIVATOR; VASCULOTROPIN; VON WILLEBRAND FACTOR; WARFARIN; FIBRINOLYTIC AGENT;

EID: 33646347663     PISSN: 18715257     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152506775268794     Document Type: Article
Times cited : (8)

References (88)
  • 9
    • 0003029141 scopus 로고    scopus 로고
    • Rubin, L.J.; Rich, S., Eds.; Marcel Dekker, Inc.: New York
    • Pietra, G.G. In Primary pulmonary hypertension; Rubin, L.J.; Rich, S., Eds.; Marcel Dekker, Inc.: New York, 1997; Vol. 99, pp. 19-61.
    • (1997) Primary Pulmonary Hypertension , vol.99 , pp. 19-61
    • Pietra, G.G.1
  • 78
    • 0030876401 scopus 로고    scopus 로고
    • Voelkel, N.F. Thorax, 1997, 52(Suppl. 3), S63.
    • (1997) Thorax , vol.52 , Issue.SUPPL. 3
    • Voelkel, N.F.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.